If you have been reading about RP-HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-11-16. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
== Description == Croton lechleri belongs to the family Euphorbiaceae and are medium-sized trees with evergreen foliage, growing 10 to 20 meters (33 to 66 ft) in height. Despite their relatively large height, the trees have very narrow trunks, averaging a bole diameter of about 30 centimeters (0.98 feet). The leaves are large, alternate cordate (heart-shaped), bright green and 15–30 cm in width and length. The flowers are greenish-white, white or amber, which produce small, three-part capsule fruits that appear on a thin spike that measures 30–50 cm. Both the smooth, mottled bark and viscous, red, latex-rich resin excreted from the wounded trunk of the tree are used medicinally.[9] While the sap can be harvested with a tap much like natural latex from rubber trees, trees that are repeatedly tapped become vulnerable to fungal infections. Croton lechleri are native to the Amazon basin and are distributed across the tropical regions of the South American countries of Bolivia, Brazil, Colombia, Ecuador, Peru, and Venezuela. They are most commonly found in the northwest lowlands between sea level up to 1000 m in elevation, mostly in mineral-rich disturbed soil and along rivers.
Electromagnetic radiation travels, when unobstructed, at the speed of light, the defined value 299,792,458 m/s in SI units. The superposition principle is always exactly true. For example, the electric potential generated by two charges is the simple addition of the potentials generated by each charge in isolation. The value of the electric field at any point around these two charges is found by calculating the vector sum of the two electric fields from each of the charges acting alone. The permittivity and permeability are exactly the electric constant ε0 and magnetic constant μ0, respectively (in SI units), or exactly 1 (in Gaussian units). The characteristic impedance (η) equals the impedance of free space Z0 ≈ 376.73 Ω. The vacuum of classical electromagnetism can be viewed as an idealized electromagnetic medium with the constitutive relations in SI units:
14 June Vodafone and Three announce a merger, pending approval from regulators, to create the largest mobile company in the UK. Thousands of people gather for a vigil to mourn the victims of the attacks in Nottingham. Police continue questioning a suspect, as the BBC obtains CCTV footage of a man believed to be the perpetrator. Researchers at the University of Cambridge report the creation of the first synthetic human embryo from stem cells, without the need for sperm or egg cells. 15 June Partygate: A 13-month investigation by the House of Commons' Privileges Committee concludes that ex-Prime Minister Johnson deliberately misled the Commons over gatherings during pandemic restrictions at 10 Downing Street and Chequers. The report proposes that he would be suspended for 90 days if still an MP. It states that he deliberately misled the House and the committee, impugned the committee and was "complicit in the campaign of abuse and attempted intimidation of the Committee". The Parole Board announces that double child killer and rapist Colin Pitchfork has been granted parole and will be released from prison. Alberto Costa, MP for South Leicestershire where the girls were killed, writes to the Justice Secretary to seek "an immediate and urgent review" of the decision. 16 June A hosepipe and sprinkler ban is announced for Kent and Sussex, beginning on 26 June, after water demand hits record levels.
=== Whole-mass determination === The protein’s whole mass is the sum of the masses of its amino-acid residues plus the mass of a water molecule and adjusted for any post-translational modifications. Although proteins ionize less well than the peptides derived from them, a protein in solution may be able to be subjected to ESI-MS and its mass measured to an accuracy of 1 part in 20,000 or better. This is often sufficient to confirm the termini (thus that the protein’s measured mass matches that predicted from its sequence) and infer the presence or absence of many post-translational modifications.
Sources: en.wikipedia.org
HVEC's first product line targeted cancer treatment, an application that demonstrated the practical value of controlled particle acceleration for medicine. Between 1948 and 1969, the company manufactured compact 2-megavolt electron accelerators designed for hospital radiotherapy departments. These 8-foot-long generators could be operated by technicians and nurses, making radiation therapy accessible beyond major research hospitals. During their production run, 35 U.S. hospitals and eight hospitals abroad installed the machines for cancer treatment. The generators addressed significant limitations in available cancer treatments. Traditional radiotherapy relied on radium sources, which were expensive, scarce, and produced uncontrolled radiation that damaged healthy tissue surrounding tumors. Low-voltage (0.25 MV) x-ray devices were available, but lacked sufficient penetration to treat deep tumors and caused violent skin reactions. HVEC's 1- and 2-MV Van de Graaff accelerators generated artificial X-rays that could be precisely aimed and modulated, allowing physicians to target deep-seated tumors while minimizing exposure to surrounding organs. The beam energy could be adjusted to match tumor depth, and therapy could be spread across multiple sessions to reduce side effects. HVEC also supported medical research.
== Sustainability == Sustainability has become a major policy objective in South Africa's logistics sector. Because road freight dominates the country's land freight system, most sustainability initiatives focus on reducing emissions from trucking, while increasing the use of rail. 2025 research on the Gauteng province's freight industry showed that many road freight companies are adopting green logistics practices, primarily through increased operational efficiency. Measures include route optimization, higher vehicle utilization and backhauling, lower-emission trucks, the use of alternative fuels, and the electrification of suitable fleets. South Africa's warehouses and logistics facilities are increasingly incorporating rooftop solar photovoltaic systems, battery storage systems, electric material-handling equipment, and energy-efficient refrigeration. Energy efficient warehousing is one of the fastest-growing sustainability measures in the South African logistics sector. Sustainable freight corridors continue to be developed in South Africa. A network of off-grid solar-powered charging infrastructure for heavy-duty electric trucks is being rolled out along major highways, by Cape Town-based company Charge. The EV charging network operator, founded in 2021, is installing 120 charging stations, designed specifically for electric trucks. The chargers are planned to be located along the N3 freight corridor between Johannesburg and Durban, with future expansion planned along the N1 corridor.
=== Adam Braverman === Adam Braverman (Peter Krause), age 40 at the beginning of the series, is Kristina's husband and the father of Max, Haddie, and Nora. He is the oldest Braverman child and all of his siblings and parents consult him in times of crisis. Adam is affable and dependable, and resolved to have a normal, happy family. Although usually in control, Adam punches a man who calls Max a "retard." Due to tensions with his boss at work, Adam was fired from the shoe company. After being unemployed and unable to find a new job, Adam goes into the music business with his brother Crosby, and together they open a recording studio called "The Luncheonette", formerly a working diner. In 2011, Adam and Kristina have their third child, a daughter named Nora. He is often shown struggling to deal with not only his own problems but those of the entire family. In season 6, when The Luncheonette business is slow, Adam takes time to teach the "culinary arts" class at Chambers Academy, the school Kristina starts. After The Luncheonette is broken into and robbed, Adam steps away from the business. After receiving an offer to re-enter the corporate world, Adam finds his passion in running Chambers Academy after Kristina begins working on opening more schools.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.